Chemical Compound

N-[(5P,8S,10R)-4-amino-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]prop-2-enamide

CAS Registry Number 1661854-97-2
返回搜索 申请报价
N-[(5P,8S,10R)-4-amino-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]prop-2-enamide 结构式
Primary record

N-[(5P,8S,10R)-4-amino-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]prop-2-enamide

库存
6,239 克
纯度
98.2 %
CAS
1661854-97-2

化合物标识与属性

CAS
1661854-97-2
PubChem CID
117918742
SMILES
CC1=C[C@@H](CN2C1=C(C3=C(N=CN=C32)N)C4=CC5=CC=CC=C5N=C4)NC(=O)C=C
Canonical SMILES
C=CC(=O)N[C@H]1C=C(C)c2c(-c3cnc4ccccc4c3)c3c(N)ncnc3n2C1

名称与同义词

  • Zipalertinib
  • TAS6417
  • 1661854-97-2
  • zipalertinibum
  • CLN-081
  • TAS-6417
  • Zipalertinib [INN]
  • CLN081
  • Cln 081
  • T4YMU8TW9H
  • TPC064
  • TPC-064
  • Zipalertinib [WHO-DD]
  • RefChem:196114
  • UNII-T4YMU8TW9H
  • TAS 6417 hydrochloride
  • ZIPALERTINIB [USAN]
  • TAS 6417
  • MFCD31715430
  • orb1307699
  • Zipalertinib (JAN/USAN/INN)
  • Pan-EGFR Inhibitor CLN-081
  • CHEMBL4650281
  • SCHEMBL16525948
  • SCHEMBL29367802
  • SCHEMBL29508462
  • SCHEMBL30274687
  • C23H20N6O
  • GTPL11889
  • TPC 064
  • CHEBI:233402
  • MKCYPWYURWOKST-INIZCTEOSA-N
  • EX-A3391
  • (S)-N-(4-amino-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl)acrylamide
  • BDBM50611355
  • NSC812926
  • s8814
  • 1661854-97-2 (free base)
  • AKOS040742682
  • Mutation-specific EGFR TKI TAS6417
  • NSC-812926
  • AC-36462
  • AS-79368
  • BT171643
  • DA-78205
  • EGFR Mutant-specific Inhibitor CLN-081
  • FT166464
  • SY318095
  • HY-112299
  • CS-0044757
  • J3.787.127C
  • D13062
  • D93895
  • Pan-mutation-selective EGFR Inhibitor CLN-081
  • A937514
  • N-[(8S)-4-Amino-6-methyl-5-quinolin-3-yl-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]prop-2-enamide
  • Pan-mutation-selective EGFR Tyrosine Kinase Inhibitor CLN-081
  • 2-Propenamide, N-((8S)-4-amino-8,9-dihydro-6-methyl-5-(3-quinolinyl)pyrimido(5,4-b)indolizin-8-yl)-
  • N-[(8S)-4-amino-6-methyl-5-(quinolin-3-yl)-8H,9H-pyrimido[5,4-b]indolizin-8-yl]prop-2-enamide
  • (S)-N-(4-amino-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido(5,4-b)indolizin-8-yl)acrylamide
  • (S)-N-[4-Amino-6-methyl-5-(3-quinolyl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]acrylamide
  • 2-Propenamide, N-[(8S)-4-amino-8,9-dihydro-6-methyl-5-(3-quinolinyl)pyrimido[5,4-b]indolizin-8-yl]-
  • N-[(5P,8S,10R)-4-amino-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]prop-2-enamide
  • N-[(8S)-4-amino-6-methyl-5-(3-quinolyl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]prop-2-enamide
  • N-[(8S)-4-amino-6-methyl-5-(quinolin-3-yl)-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]prop-2-enamide
  • Propenamide, N-[(8S)-4-amino-8,9-dihydro-6-methyl-5-(3-quinolinyl)pyrimido[5,4-b]indolizin-8-yl]- (ACI)